| |
|
|
|
Catalyst Biosciences Inc.  
|
|
8.23 -0.04 (-0%) |
07-22 10:01 |
|
Open: |
8.21 |
Pre close: |
8.27 |
Target:
|
10.35
|
|
High: |
8.27 |
Low: |
7.99 |
Resistance:
|
8.86
9.96
|
|
Volume: |
19,735 |
Market Cap: |
99M |
Support:
|
7.08
5.89
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.43
 |
MACD |
MACD(12,26):
|
0.18 |
|
MA(20): |
8.07  |
Signal(12,26,9): |
0.14 |
|
MA(100): |
8.42 |
Stochastic Oscillator |
%K(14,3):
|
43.08 |
|
MA(250): |
9.14 |
%D(3): |
45.53 |
|
Average Volume(K) |
3-Month: |
21881
|
52-Week |
High:
|
11.44 |
|
10-Days: |
32682 |
Low: |
6.20 |
|
RSI |
RSI(14):
|
52.66 |
Change(%): |
-20.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.350 |
Return on Equity (ttm) |
-32.3 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-7.910 |
Return on Assets (ttm) |
-20.7 |
Shares Float (M) |
8.79 |
|
EPS Est. Next Year |
-4.810 |
PEG Ratio |
0.08 |
% Held by Insiders |
7.05 |
|
EPS Est. Next Quarter |
-1.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
72.91 |
|
Forward EPS |
-4.863 |
Gross Profit (p.s.) |
-1.792 |
Shares Short (K) |
1060 |
|
Book Value (p.s.) |
8.840 |
EBITDA (p.s.) |
-3.556 |
P/E |
-2.47 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.94 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-38.40 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-24.72 |
P/CF |
-0.00 |
|
|
|
|
|
|
